Free Trial

Relay Therapeutics (RLAY) Earnings Date, Estimates & Call Transcripts

Relay Therapeutics logo
$4.16 -0.10 (-2.35%)
(As of 12/20/2024 05:45 PM ET)

Relay Therapeutics Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.63 Beat By $0.14
Consensus EPS
(Nov. 6)
-$0.77

Relay Therapeutics issued Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.63, which beat analysts' consensus estimates of -$0.77 by $0.14. Its quarterly revenue was down 100.0% on a year-over-year basis. With a trailing EPS of -$2.61, Relay Therapeutics' earnings are expected to decrease next year, from ($2.55) to ($2.73) per share.

Get Relay Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Relay Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RLAY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RLAY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Relay Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.82-$0.63-$0.73
Q2 20242-$0.85-$0.73-$0.79
Q3 20242-$0.81-$0.70-$0.76
Q4 20242-$0.54-$0.39-$0.47
FY 20248-$3.02-$2.45-$2.74
Q1 20251-$0.56-$0.56-$0.56
Q2 20251-$0.58-$0.58-$0.58
Q3 20251-$0.60-$0.60-$0.60
Q4 20251-$0.61-$0.61-$0.61
FY 20254($2.35)($2.35)($2.35)

Relay Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024Q3 2024-$0.77-$0.63+$0.14-$0.63$0.09M-
8/6/2024Q2 2024-$0.73-$0.69+$0.04-$0.69$0.09M-
5/2/2024Q1 2024-$0.70-$0.62+$0.08-$0.62$0.12M$10.01M
2/22/2024Q4 2023-$0.76-$0.67+$0.09-$0.67$0.64M-
11/2/2023Q3 2023-$0.83-$0.54+$0.29-$0.54$0.78M$25.20M
8/8/2023Q2 2023-$0.78-$0.81 -$0.03-$0.81$0.81M$0.12M
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

5/4/2023Q1 2023-$0.70-$0.78 -$0.08-$0.78$0.16M$0.23M
2/23/2023Q4 2022-$0.68-$0.56+$0.12-$0.56$0.18M$0.25M

Relay Therapeutics Earnings - Frequently Asked Questions

Relay Therapeutics (NASDAQ:RLAY) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on RLAY's earnings history.

In the previous quarter, Relay Therapeutics (NASDAQ:RLAY) reported ($0.63) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.77) by $0.14. Learn more on analysts' earnings estimate vs. RLAY's actual earnings.

Relay Therapeutics (NASDAQ:RLAY) has a recorded annual revenue of $10.01 million.

Relay Therapeutics (NASDAQ:RLAY) has a recorded net income of -$341.97 million. RLAY has generated -$2.61 earnings per share over the last four quarters.

Relay Therapeutics's earnings are expected to decrease from ($2.55) per share to ($2.73) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:RLAY) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners